» Articles » PMID: 36711119

Item Selection for a New Health-Related Quality of Life Measure for Parkinson's Disease: The Preference-Based Parkinson's Disease Index (PB-PDI)

Overview
Journal Neurol Res Int
Publisher Wiley
Specialty Neurology
Date 2023 Jan 30
PMID 36711119
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Parkinson's disease (PD) is a neurodegenerative condition, predominantly affecting older adults. Preference-based measures (PBMs) can be used to make decisions about the cost-utility of different treatments. There are currently no PBMs for health-related quality of life (HRQoL) for PD. A previous study identified important health domains for individuals with PD and developed an item pool from existing measures per domain. The current study aims to contribute to the development of a new disease-specific PBM of HRQoL for PD by reducing the current pool of items according to the preferences of individuals with PD.

Methods: Fifty-three participants completed a visual analogue scale (VAS) of self-perceived health, the prototype PBM measure, and an item importance rating. To reduce the item pool, the following were calculated: (1) inter-item correlations; (2) impact of each item based on item performance and importance rating; (3) directionality of response options by comparing the VAS scores against each item.

Results: Participants (male = 54.7%, age = 60.0 ± 10.2) had a median Hoehn and Yahr score of 2.5 (interquartile range = 1). Items supported for inclusion by this analysis were sleep, fatigue, tremor, mood, walking, memory, and dexterity. Items demonstrating a logical decrease in VAS score with each increasing severity level were sleep, memory, tremor, fatigue, and mood.

Conclusion: This PBM will be critical for informing decisions about the cost-utility of PD treatments, guiding the resource allocation within our healthcare system. Future research will include cognitive debriefing with individuals with PD to refine item response options.

Citing Articles

Use of advanced topic modeling to generate domains for a preference-based index in osteoarthritis.

Kuspinar A, Na E, Hum S, Jones A, Mayo N Health Qual Life Outcomes. 2024; 22(1):113.

PMID: 39736714 PMC: 11686952. DOI: 10.1186/s12955-024-02331-1.

References
1.
Cusso M, Donald K, Khoo T . The Impact of Physical Activity on Non-Motor Symptoms in Parkinson's Disease: A Systematic Review. Front Med (Lausanne). 2016; 3:35. PMC: 4987718. DOI: 10.3389/fmed.2016.00035. View

2.
Stowe R, Ives N, Clarke C, van Hilten J, Ferreira J, Hawker R . Dopamine agonist therapy in early Parkinson's disease. Cochrane Database Syst Rev. 2008; (2):CD006564. DOI: 10.1002/14651858.CD006564.pub2. View

3.
Stenzelius K, Molander U, Odeberg J, Hammarstrom M, Franzen K, Midlov P . The effect of conservative treatment of urinary incontinence among older and frail older people: a systematic review. Age Ageing. 2015; 44(5):736-44. DOI: 10.1093/ageing/afv070. View

4.
Mukaka M . Statistics corner: A guide to appropriate use of correlation coefficient in medical research. Malawi Med J. 2013; 24(3):69-71. PMC: 3576830. View

5.
Pogarell O, Gasser T, van Hilten J, Spieker S, Pollentier S, Meier D . Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study. J Neurol Neurosurg Psychiatry. 2002; 72(6):713-20. PMC: 1737934. DOI: 10.1136/jnnp.72.6.713. View